Imbruvica (Ibrutinib)
Indication: | Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia) |
---|---|
Active Ingredient (Generic Name): | Ibrutinib |
Manufacturer: | Johnson & Johnson |
Dosage Form: | Capsule |
Delivery Time: | 6 To 15 days |
|
Indication: | Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia) |
---|---|
Active Ingredient (Generic Name): | Ibrutinib |
Manufacturer: | Johnson & Johnson |
Dosage Form: | Capsule |
Delivery Time: | 6 To 15 days |
|
Reviews
There are no reviews yet.